{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:21:45Z","timestamp":1783923705577,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"44","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.vaccine.2017.05.092","type":"journal-article","created":{"date-parts":[[2017,6,10]],"date-time":"2017-06-10T16:17:07Z","timestamp":1497111427000},"page":"5995-6006","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Novel CTL epitopes identified through a Y. pestis proteome-wide analysis in the search for vaccine candidates against plague"],"prefix":"10.1016","volume":"35","author":[{"given":"Anat","family":"Zvi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahar","family":"Rotem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayelet","family":"Zauberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uri","family":"Elia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Aftalion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erez","family":"Bar-Haim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuelle","family":"Mamroud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofer","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.05.092_b0005","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1086\/604718","article-title":"Plague into the 21st century","volume":"49","author":"Butler","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.05.092_b0010","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1086\/428617","article-title":"Risk of person-to-person transmission of pneumonic plague","volume":"40","author":"Kool","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.05.092_b0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/CMR.10.1.35","article-title":"Yersinia pestis\u2013etiologic agent of plague","volume":"10","author":"Perry","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2017.05.092_b0020","first-page":"2281","article-title":"Plague as a biological weapon: medical and public health management","volume":"283","author":"Inglesby","year":"2000","journal-title":"Working Group Civil Biodefense JAMA"},{"key":"10.1016\/j.vaccine.2017.05.092_b0025","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM199709043371004","article-title":"Multidrug resistance in Yersinia pestis mediated by a transferable plasmid","volume":"337","author":"Galimand","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.05.092_b0030","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1016\/j.vaccine.2007.01.071","article-title":"Development of a recombinant vaccine against aerosolized plague","volume":"25","author":"Morris","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.092_b0035","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1128\/IAI.73.6.3598-3608.2005","article-title":"Human immune response to a plague vaccine comprising recombinant F1 and V antigens","volume":"73","author":"Williamson","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.05.092_b0040","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4269\/ajtmh.1997.56.471","article-title":"Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestis","volume":"56","author":"Anderson","year":"1997","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2017.05.092_b0045","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1128\/IAI.71.4.2234-2238.2003","article-title":"Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis","volume":"71","author":"Hill","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.05.092_b0050","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1128\/IAI.73.11.7304-7310.2005","article-title":"Cell-mediated protection against pulmonary Yersinia pestis infection","volume":"73","author":"Parent","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.05.092_b0055","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.micpath.2004.06.009","article-title":"Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague","volume":"37","author":"Elvin","year":"2004","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2017.05.092_b0060","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1128\/IAI.00242-09","article-title":"High-throughput identification of new protective antigens from a Yersinia pestis live vaccine by enzyme-linked immunospot assay","volume":"77","author":"Li","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.05.092_b0065","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.vaccine.2010.08.099","article-title":"TNF\u03b1 and IFN\u03b3 contribute to F1\/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague","volume":"29","author":"Lin","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.092_b0070","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1586\/14760584.7.2.209","article-title":"Current challenges in the development of vaccines for pneumonic plague","volume":"7","author":"Smiley","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.05.092_b0075","doi-asserted-by":"crossref","first-page":"D405","DOI":"10.1093\/nar\/gku938","article-title":"The immune epitope database (IEDB) 3.0","volume":"43","author":"Vita","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2017.05.092_b0080","doi-asserted-by":"crossref","first-page":"897","DOI":"10.4049\/jimmunol.1100174","article-title":"Yersinia pestis YopE contains a dominant CD8 T cell epitope that confers protection in a mouse model of pneumonic plague","volume":"187","author":"Lin","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.05.092_b0085","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2567.2010.03300.x","article-title":"Major histocompatibility complex class I binding predictions as a tool in epitope discovery","volume":"130","author":"Lundegaard","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2017.05.092_b0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13073-016-0288-x","article-title":"NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets","volume":"8","author":"Nielsen","year":"2016","journal-title":"Genome Med"},{"key":"10.1016\/j.vaccine.2017.05.092_b0095","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/nbt1215","article-title":"A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus","volume":"24","author":"Moutaftsi","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2017.05.092_b0100","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.vaccine.2005.01.059","article-title":"Developing an epitope-driven tuberculosis (TB) vaccine","volume":"23","author":"De Groot","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.092_b0105","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1016\/j.vaccine.2007.01.039","article-title":"Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine","volume":"25","author":"McMurry","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.092_b0110","doi-asserted-by":"crossref","first-page":"e20050","DOI":"10.1371\/journal.pone.0020050","article-title":"Whole-genome immunoinformatic analysis of F. tularensis: predicted CTL epitopes clustered in hotspots are prone to elicit a T-cell response","volume":"6","author":"Zvi","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.05.092_b0115","doi-asserted-by":"crossref","first-page":"e36440","DOI":"10.1371\/journal.pone.0036440","article-title":"Clusters versus affinity-based approaches in F. tularensis whole genome search of CTL epitopes","volume":"7","author":"Zvi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.05.092_b0120","doi-asserted-by":"crossref","first-page":"e85215","DOI":"10.1371\/journal.pone.0085215","article-title":"Protective immunity against lethal F. tularensis holarctica LVS provided by vaccination with selected novel CD8+ T cell epitopes","volume":"9","author":"Rotem","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.05.092_b0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00251-011-0579-8","article-title":"NetMHCcons: a consensus method for the major histocompatibility complex class I predictions","volume":"64","author":"Karosiene","year":"2012","journal-title":"Immunogenetics"},{"key":"10.1016\/j.vaccine.2017.05.092_b0130","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkn202","article-title":"NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8\u201311","volume":"36","author":"Lundegaard","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2017.05.092_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00251-008-0341-z","article-title":"NetMHCpan, a method for MHC class I binding prediction beyond humans","volume":"61","author":"Hoof","year":"2009","journal-title":"Immunogenetics"},{"key":"10.1016\/j.vaccine.2017.05.092_b0140","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/bioinformatics\/btp137","article-title":"The PickPocket method for predicting binding specificities for receptors based on receptor pocket similarities: application to MHC-peptide binding","volume":"25","author":"Zhang","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vaccine.2017.05.092_b0145","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/bioinformatics\/btv639","article-title":"Gapped sequence alignment using artificial neural networks: application to the MHC class I system","volume":"32","author":"Andreatta","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vaccine.2017.05.092_b0150","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1471-2105-6-132","article-title":"Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method","volume":"6","author":"Peters","year":"2005","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.vaccine.2017.05.092_b0155","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1745-7580-4-2","article-title":"Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries","volume":"4","author":"Sidney","year":"2008","journal-title":"Immunome Res"},{"key":"10.1016\/j.vaccine.2017.05.092_b0160","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00251-010-0493-5","article-title":"HLArestrictor\u2013a tool for patient-specific predictions of HLA restriction elements and optimal epitopes within peptides","volume":"63","author":"Erup Larsen","year":"2011","journal-title":"Immunogenetics"},{"key":"10.1016\/j.vaccine.2017.05.092_b0165","doi-asserted-by":"crossref","first-page":"e7023","DOI":"10.1371\/journal.pone.0007023","article-title":"The NlpD lipoprotein is a novel Yersinia pestis virulence factor essential for the development of plague","volume":"4","author":"Tidhar","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.05.092_b0170","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1128\/IAI.00097-06","article-title":"Interaction of Yersinia pestis with macrophages: limitations in YopJ-dependent apoptosis","volume":"74","author":"Zauberman","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.05.092_b0175","doi-asserted-by":"crossref","first-page":"P98","DOI":"10.1186\/1475-2859-5-S1-P98","article-title":"Production and purification of high molecular weight oligomers of Yersinia pestis F1 capsular antigen released by high cell density culture of recombinant Escherichia coli cells carrying the caf1 operon","volume":"5","author":"Holtzman","year":"2006","journal-title":"Microb Cell Factories"},{"key":"10.1016\/j.vaccine.2017.05.092_b0180","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.vaccine.2008.01.033","article-title":"Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague","volume":"26","author":"Zauberman","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.092_b0185","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1006\/jmbi.2000.4315","article-title":"Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes","volume":"305","author":"Krogh","year":"2001","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2017.05.092_b0190","first-page":"175","article-title":"A hidden Markov model for predicting transmembrane helices in protein sequences","volume":"6","author":"Sonnhammer","year":"1998","journal-title":"Proc Int Conf Intell Syst Mol Biol"},{"key":"10.1016\/j.vaccine.2017.05.092_b0195","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jmb.2004.05.028","article-title":"Improved prediction of signal peptides: SignalP 3.0","volume":"340","author":"Bendtsen","year":"2004","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2017.05.092_b0200","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.intimp.2012.10.029","article-title":"Multiple antigen peptide consisting of B- and T-cell epitopes of F1 antigen of Y. pestis showed enhanced humoral and mucosal immune response in different strains of mice","volume":"15","author":"Ali","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.vaccine.2017.05.092_b0205","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.intimp.2011.10.012","article-title":"Evaluation of CD4+\/CD8+ T-cell expression and IFN-\u03b3, perforin secretion for B-T constructs of F1 and V antigens of Yersinia pestis","volume":"12","author":"Gupta","year":"2012","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.vaccine.2017.05.092_b0210","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cellimm.2012.07.002","article-title":"Cell-mediated immune response to epitopic MAP (multiple antigen peptide) construct of LcrV antigen of Yersinia pestis in murine model","volume":"278","author":"Shreewastav","year":"2012","journal-title":"Cell Immunol"},{"key":"10.1016\/j.vaccine.2017.05.092_b0215","doi-asserted-by":"crossref","first-page":"6802","DOI":"10.1016\/j.vaccine.2010.12.062","article-title":"Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge","volume":"29","author":"Wang","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.092_b0220","doi-asserted-by":"crossref","first-page":"E1754","DOI":"10.1073\/pnas.1500973112","article-title":"TCR contact residue hydrophobicity is a hallmark of immunogenic CD8+ T cell epitopes","volume":"112","author":"Chowell","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2017.05.092_b0225","doi-asserted-by":"crossref","first-page":"e1003266","DOI":"10.1371\/journal.pcbi.1003266","article-title":"Properties of MHC class I presented peptides that enhance immunogenicity","volume":"9","author":"Calis","year":"2013","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.vaccine.2017.05.092_b0230","doi-asserted-by":"crossref","unstructured":"Chakraborty S, Rahman T, Chakravorty R. Characterization of the protective HIV-1 CTL epitopes and the corresponding HLA class I alleles: a step towards designing CTL based HIV-1 vaccine. Adv Virol 2014; 2014.","DOI":"10.1155\/2014\/321974"},{"key":"10.1016\/j.vaccine.2017.05.092_b0235","doi-asserted-by":"crossref","unstructured":"Coleman HN, Wang X, Greefield WW, Nakagawwa M. A Human papillomavirus type 16 E6 52-62 CD4 T-cell epitope restricted by the HLA-DR11 molecule described in an epitope hotspot. MOJ Immunol 2014; 1.","DOI":"10.15406\/moji.2014.01.00018"},{"key":"10.1016\/j.vaccine.2017.05.092_b0240","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1128\/JVI.02642-14","article-title":"T cell epitope clustering in the highly immunogenic BZLF1 antigen of Epstein-Barr virus","volume":"89","author":"Rist","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.05.092_b0245","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.coi.2015.01.013","article-title":"Discovering protective CD8 T cell epitopes\u2013no single immunologic property predicts it!","volume":"34","author":"Gilchuk","year":"2015","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2017.05.092_b0250","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.cimid.2013.01.002","article-title":"B and T cell epitope mapping and study the humoral and cell mediated immune response to B-T constructs of YscF antigen of Yersinia pestis","volume":"36","author":"Ali","year":"2013","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2017.05.092_b0255","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.4049\/jimmunol.1203253","article-title":"Fibrin facilitates both innate and T cell-mediated defense against Yersinia pestis","volume":"190","author":"Luo","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.05.092_b0260","doi-asserted-by":"crossref","first-page":"e1004142","DOI":"10.1371\/journal.ppat.1004142","article-title":"TNF\u03b1 and IFN\u03b3 but not perforin are critical for CD8 T cell-mediated protection against pulmonary Yersinia pestis infection","volume":"10","author":"Szaba","year":"2014","journal-title":"PLoS Pathog"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17307624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17307624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T21:49:33Z","timestamp":1569448173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17307624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":52,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0264410X17307624"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.092","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel CTL epitopes identified through a Y. pestis proteome-wide analysis in the search for vaccine candidates against plague","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}